TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS
Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case - ACE inhibitors or ARB?...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Book |
Published: |
Столичная издательская компания,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_2bc9a1d3fe8e4af1bb5f13ce8347dc73 | ||
042 | |a dc | ||
100 | 1 | 0 | |a L. N. Malay |e author |
700 | 1 | 0 | |a A. N. Miroshnichenko |e author |
700 | 1 | 0 | |a B. V. Sharykin |e author |
700 | 1 | 0 | |a V. V. Konurovsky |e author |
245 | 0 | 0 | |a TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS |
260 | |b Столичная издательская компания, |c 2016-01-01T00:00:00Z. | ||
500 | |a 1819-6446 | ||
500 | |a 2225-3653 | ||
500 | |a 10.20996/1819-6446-2009-5-4-85-92 | ||
520 | |a Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications. What it is better to prescribe for patient in a concrete clinical case - ACE inhibitors or ARB? Authors compare these drug classes (mechanism of action, indications, evidense base of clinical trails, treatment costs and safety). The place of ACE inhibitors and ARB in modern therapy of cardiovascular diseases is defined. Results of the recent trails (ONTARGET, TRANCEND, PRoFESS, I-PRESERVE) are discussed. | ||
546 | |a EN | ||
546 | |a RU | ||
690 | |a angiotensin converting enzyme inhibitors | ||
690 | |a angiotensin ii receptor blockers | ||
690 | |a cardiovascular diseases | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Diseases of the circulatory (Cardiovascular) system | ||
690 | |a RC666-701 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Рациональная фармакотерапия в кардиологии, Vol 5, Iss 4, Pp 85-92 (2016) | |
787 | 0 | |n https://www.rpcardio.online/jour/article/view/694 | |
787 | 0 | |n https://doaj.org/toc/1819-6446 | |
787 | 0 | |n https://doaj.org/toc/2225-3653 | |
856 | 4 | 1 | |u https://doaj.org/article/2bc9a1d3fe8e4af1bb5f13ce8347dc73 |z Connect to this object online. |